Schor Chen bought KPTI
May 21, 2026 · Form 4 insider transaction
Schor Chen bought 15,508 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,508
Price
$0.00
Total value
N/A
InsiderSchor Chen
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 21, 2026
Filing dateMay 26, 2026
Shares owned after15,508
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest 100% on May 21, 2027; however, delivery of the shares is deferred until the earlier of (a) the date of the director's separation from service to Karyopharm Therapeutics Inc. and (b) a change-in-control event.